Substrates for efficient fluorometric screening employing the NAD-dependent sirtuin 5 lysine deacylase (KDAC) enzyme

Journal of Medicinal Chemistry

Volumn 55, Issue 11, 2012, Pages 5582-5590

  Madsen, Andreas S ^a   Olsen, Christian A ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7; SURAMIN;

ACYLATION; ARTICLE; DEACETYLATION; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SUBSTRATE; FLUOROMETRY; HUMAN; PROTEIN PROCESSING; X RAY CRYSTALLOGRAPHY;

BENZAMIDES; COUMARINS; ENZYME ASSAYS; FLUOROMETRY; FURANS; HUMANS; ISOENZYMES; KINETICS; LYSINE; NAPHTHOLS; PROTEIN PROCESSING, POST-TRANSLATIONAL; QUINOLINES; RECOMBINANT PROTEINS; SIRTUINS; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; SUCCINIC ACIDS; SURAMIN;

EID: 84862271824     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm300526r     Document Type: Article

References (45)

1. Biel, M.; Wascholowski, V.; Giannis, A. Epigenetics-an epicenter of gene regulation: histones and histone-modifying enzymes Angew. Chem., Int. Ed. 2005, 44, 3186-3216
2. +-dependent histone deacetylases (sirtuins) as novel therapeutic targets Med. Res. Rev. 2010, 30, 861-889
3. Denu, J. M. The Sir2 family of protein deacetylases Curr. Opin. Chem. Biol. 2005, 9, 431-440
4. Cole, P. A. Chemical probes for histone-modifying enzymes Nat. Chem. Biol. 2008, 4, 590-597
5. Haigis, M. C.; Sinclair, D. A. Mammalian sirtuins: biological insights and disease relevance Annu. Rev. Pathol.: Mech. Dis. 2010, 5, 253-295
6. Herranz, D.; Serrano, M. SIRT1: recent lessons from mouse models Nat. Rev. Cancer 2010, 10, 819-823
7. Blum, C. A.; Ellis, J. L.; Loh, C.; Ng, P.-Y.; Perni, R. B.; Stein, R. L. SIRT1 modulation as a novel approach to the treatment of diseases of aging J. Med. Chem. 2011, 54, 417-432
8. Milne, J. C.; Denu, J. M. The Sirtuin family: therapeutic targets to treat diseases of aging Curr. Opin. Chem. Biol. 2008, 12, 11-17
9. Jackson, M. D.; Schmidt, M. T.; Oppenheimer, N. J.; Denu, J. M. Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases J. Biol. Chem. 2003, 278, 50985-50998
10. Smith, B. C.; Denu, J. M. Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases J. Biol. Chem. 2007, 282, 37256-37265
11. Smith, B. C.; Hallows, W. C.; Denu, J. M. Mechanisms and molecular probes of sirtuins Chem. Biol. 2008, 15, 1002-1013
12. Cen, Y.; Sauve, A. A. Transition state of ADP-ribosylation of acetyllysine catalyzed by Archaeoglobus fulgidus Sir2 determined by kinetic isotope effects and computational approaches J. Am. Chem. Soc. 2010, 132, 12286-12298
13. Finnin, M. S.; Donigian, J. R.; Pavletich, N. P. Structure of the histone deacetylase SIRT2 Nat. Struct. Biol. 2001, 8, 621-625
14. +-dependent deacetylase SIRT5 by suramin Structure 2007, 15, 377-389
15. Jin, L.; Wei, W.; Jiang, Y.; Peng, H.; Cai, J.; Mao, C.; Dai, H.; Choy, W.; Bemis, J. E.; Jirousek, M. R.; Milne, J. C.; Westphal, C. H.; Perni, R. B. Crystal structures of human SIRT3 displaying substrate-induced conformational changes J. Biol. Chem. 2009, 284, 24394-24405
16. Min, J.; Landry, J.; Sternglanz, R.; Xu, R. M. Crystal structure of a SIR2 homolog-NAD complex Cell 2001, 105, 269-279
17. Avalos, J. L.; Celic, I.; Muhammad, S.; Cosgrove, M. S.; Boeke, J. D.; Wolberger, C. Structure of a Sir2 enzyme bound to an acetylated p53 peptide Mol. Cell 2002, 10, 523-535
18. +-dependent tubulin deacetylase Mol. Cell 2003, 11, 437-444
19. Blander, G.; Guarente, L. The Sir2 family of protein deacetylases Annu. Rev. Biochem. 2004, 73, 417-435
20. Haigis, M. C.; Mostoslavsky, R.; Haigis, K. M.; Fahie, K.; Christodoulou, D. C.; Murphy, A. J.; Valenzuela, D. M.; Yancopoulos, G. D.; Karow, M.; Blander, G.; Wolberger, C.; Prolla, T. A.; Weindruch, R.; Alt, F. W.; Guarente, L. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells Cell 2006, 126, 941-954
21. Du, J.; Zhou, Y.; Su, X.; Yu, J. J.; Khan, S.; Jiang, H.; Kim, J.; Woo, J.; Kim, J. H.; Choi, B. H.; He, B.; Chen, W.; Zhang, S.; Cerione, R. A.; Auwerx, J.; Hao, Q.; Lin, H. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase Science 2011, 334, 806-809
22. Olsen, C. A. Expansion of the lysine acylation landscape Angew. Chem., Int. Ed. 2012, 51, 3755-3756
23. Michishita, E.; McCord, R. A.; Berber, E.; Kioi, M.; Padilla-Nash, H.; Damian, M.; Cheung, P.; Kusumoto, R.; Kawahara, T. L. A.; Barrett, J. C.; Chang, H. Y.; Bohr, V. A.; Ried, T.; Gozani, O.; Chua, K. F. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin Nature 2008, 452, 492-496
24. Bradner, J. E.; West, N.; Grachan, M. L.; Greenberg, E. F.; Haggarty, S. J.; Warnow, T.; Mazitschek, R. Chemical phylogenetics of histone deacetylases Nat. Chem. Biol. 2010, 6, 238-243
25. Tan, M.; Luo, H.; Lee, S.; Jin, F.; Yang, J. S.; Montellier, E.; Buchou, T.; Cheng, Z.; Rousseaux, S.; Rajagopal, N.; Lu, Z.; Ye, Z.; Zhu, Q.; Wysocka, J.; Ye, Y.; Khochbin, S.; Ren, B.; Zhao, Y. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification Cell 2011, 146, 1016-1028
26. Heltweg, B.; Dequiedt, F.; Marshall, B. L.; Brauch, C.; Yoshida, M.; Nishino, N.; Verdin, E.; Jung, M. Subtype selective substrates for histone deacetylases J. Med. Chem. 2004, 47, 5235-5243
27. He, B.; Du, J.; Lin, H. Thiosuccinyl peptides as SIRT5-specific inhibitors J. Am. Chem. Soc. 2012, 134, 1922-1925
28. Vaziri, H.; Dessain, S. K.; Ng Eaton, E.; Imai, S. I.; Frye, R. A.; Pandita, T. K.; Guarente, L.; Weinberg, R. A. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase Cell 2001, 107, 149-159
29. Solomon, J. M.; Pasupuleti, R.; Xu, L.; McDonagh, T.; Curtis, R.; DiStefano, P. S.; Huber, L. J. Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage Mol. Cell. Biol. 2006, 26, 28-38
30. Smith, B. C.; Denu, J. M. Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide Biochemistry 2007, 46, 14478-14486
31. Xu, C.; Soragni, E.; Chou, C. J.; Herman, D.; Plasterer, H. L.; Rusche, J. R.; Gottesfeld, J. M. Chemical probes identify a role for histone deacetylase 3 in Friederich's Ataxia gene silencing Chem. Biol. 2009, 16, 980-989
32. Chou, C. J.; Herman, D.; Gottesfeld, J. M. Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I histone deacetylases J. Biol. Chem. 2008, 283, 35402-35409
33. 2+-binding functional group, ACS Med. Chem. Lett. [Online early access]. DOI: 10.1021/ml300081u. Published Online: Apr 26, 2012.
34. Grozinger, C. M.; Chao, E. D.; Blackwell, H. E.; Moazed, D.; Schreiber, S. L. Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening J. Biol. Chem. 2001, 276, 38837-38843
35. Outeiro, T. F.; Kontopoulos, E.; Altmann, S. M.; Kufareva, I.; Strathearn, K. E.; Amore, A. M.; Volk, C. B.; Maxwell, M. M.; Rochet, J. C.; McLean, P. J.; Young, A. B.; Abagyan, R.; Feany, M. B.; Hyman, B. T.; Kazantsev, A. G. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease Science 2007, 317, 516-519
36. +-dependent histone deacetylases (sirtuins) ChemMedChem 2007, 2, 1419-1431
37. Fatkins David, G.; Monnot Andrew, D.; Zheng, W. N- epsilon-Thioacetyl- lysine: a multi-facet functional probe for enzymatic protein lysine N -epsilon-deacetylation Bioorg. Med. Chem. Lett. 2006, 16, 3651-3656
38. Huhtiniemi, T.; Salo, H. S.; Suuronen, T.; Poso, A.; Salminen, A.; Leppanen, J.; Jarho, E.; Lahtela-Kakkonen, M. Structure-based design of pseudopeptidic inhibitors for SIRT1 and SIRT2 J. Med. Chem. 2011, 54, 6456-6468
39. Borra, M. T.; Smith, B. C.; Denu, J. M. Mechanism of human SIRT1 activation by resveratrol J. Biol. Chem. 2005, 280, 17187-17195
40. Kaeberlein, M.; McDonagh, T.; Heltweg, B.; Hixon, J.; Westman, E. A.; Caldwell, S. D.; Napper, A.; Curtis, R.; DiStefano, P. S.; Fields, S.; Bedalov, A.; Kennedy, B. K. Substrate-specific activation of sirtuins by resveratrol J. Biol. Chem. 2005, 280, 17038-17045
41. Beher, D.; Wu, J.; Cumine, S.; Kim, K. W.; Lu, S. C.; Atangan, L.; Wang, M. Resveratrol is not a direct activator of SIRT1 enzyme activity Chem. Biol. Drug Des. 2009, 74, 619-624
42. Pacholec, M.; Bleasdale, J. E.; Chrunyk, B.; Cunningham, D.; Flynn, D.; Garofalo, R. S.; Griffith, D.; Griffor, M.; Loulakis, P.; Pabst, B.; Qiu, X.; Stockman, B.; Thanabal, V.; Varghese, A.; Ward, J.; Withka, J.; Ahn, K. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1 J. Biol, Chem. 2010, 285, 8340-8351
43. Lineweaver, H.; Burk, D. The determination of enzyme dissociation constants J. Am. Chem. Soc. 1934, 56, 658-666
44. m Anal. Biochem. 1994, 221, 53-56
45. Wegener, D.; Wirsching, F.; Riester, D.; Schweinhorst, A. A fluorogenic histone deacetylase assay well suited for high-throughput activity screening Chem. Biol. 2003, 10, 61-68